morphine sulfate injection, USP 25 MG/ML, 50 MG/ML VIAL How Supplied/Storage and Handling

()

HOW SUPPLIED

Morphine Sulfate Injection, USP, is available in glass fliptop vials as follows:

25 mg/mL Morphine Sulfate Injection, USP, Preservative Free (no bacteriostat or antioxidant added).

Single-dose vials.1

Unit of SaleConcentration
NDC 0409-1135-02
Carton of 1 Single-dose Fliptop Vial
250 mg/10 mL
(25 mg/mL)

50 mg/mL Morphine Sulfate Injection, USP (no bacteriostat added).

Single-dose vials.1

Unit of SaleConcentration
NDC 0409-1134-03
Carton of 1 Single-dose Fliptop Vial
1,000 mg/20 mL
(50 mg/mL)
NDC 0409-1134-05
Carton of 1 Single-dose Fliptop Vial
2,500 mg/50 mL
(50 mg/mL)

FOR INTRAVENOUS USE ONLY AFTER DILUTION.

NOT FOR DIRECT INJECTION.

THESE PRODUCTS ARE INTENDED FOR INTRAVENOUS USE ONLY.

NOT INTENDED FOR INTRATHECAL OR EPIDURAL USE.


1
Contains no antimicrobial preservatives.

Storage

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Morphine sulfate solutions may darken with age. Do not use if injection is darker than pale yellow, discolored in any other way, or contains a precipitate. Do not heat-sterilize the Preservative Free (antioxidant free) formula.

PROTECT FROM LIGHT

Find morphine sulfate injection, USP 25 MG/ML, 50 MG/ML VIAL medical information:

Find morphine sulfate injection, USP 25 MG/ML, 50 MG/ML VIAL medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

morphine sulfate injection, USP 25 MG/ML, 50 MG/ML VIAL Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

HOW SUPPLIED

Morphine Sulfate Injection, USP, is available in glass fliptop vials as follows:

25 mg/mL Morphine Sulfate Injection, USP, Preservative Free (no bacteriostat or antioxidant added).

Single-dose vials.1

Unit of SaleConcentration
NDC 0409-1135-02
Carton of 1 Single-dose Fliptop Vial
250 mg/10 mL
(25 mg/mL)

50 mg/mL Morphine Sulfate Injection, USP (no bacteriostat added).

Single-dose vials.1

Unit of SaleConcentration
NDC 0409-1134-03
Carton of 1 Single-dose Fliptop Vial
1,000 mg/20 mL
(50 mg/mL)
NDC 0409-1134-05
Carton of 1 Single-dose Fliptop Vial
2,500 mg/50 mL
(50 mg/mL)

FOR INTRAVENOUS USE ONLY AFTER DILUTION.

NOT FOR DIRECT INJECTION.

THESE PRODUCTS ARE INTENDED FOR INTRAVENOUS USE ONLY.

NOT INTENDED FOR INTRATHECAL OR EPIDURAL USE.


1
Contains no antimicrobial preservatives.

Storage

Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Morphine sulfate solutions may darken with age. Do not use if injection is darker than pale yellow, discolored in any other way, or contains a precipitate. Do not heat-sterilize the Preservative Free (antioxidant free) formula.

PROTECT FROM LIGHT

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.